https://www.selleckchem.com/pr....oducts/bevacizumab.h
In terms of treatment intensity, initial severity moderated effect of treatment intensity on only one domain - change in autism symptom severity, and in a secondary analysis, this effect was found in only one site. Neither treatment style or intensity had overall effects on child outcomes in the four domains examined. Initial severity did not predict better response to one intervention style than another. We found very limited evidence that initial severity predicted better response to 25 versus 15 hours per week of intervention in